Executive Director, Global Regulatory Affairs @ (February 2024 - March 2026)
Senior Director, Global Regulatory Affairs @ (February 2022 - February 2024)
Director, Global Regulatory Affairs @ (October 2019 - February 2022)
Director, Global Regulatory Affairs, Regulatory Strategy and Agency Liaison @ (October 2018 - October 2019)
Associate Principal Specialist - Regulatory Drug Project Development @ (April 2017 - October 2018)
Associate Regulatory Project Director @ (July 2013 - June 2016)
Global Product Manager @ (May 2011 - July 2013)
Associate Director, Regulatory Affairs @ (October 2008 - May 2011)
Regulatory Affairs Manager @ (October 2006 - September 2008)
Regulatory Project Associate @ (January 2004 - October 2006)
Project Manager and Project Leader and Research Scientist @ Message Pharmaceuticals (September 1995 - December 2002)
Postdoctoral Fellow @ DuPont Merck (January 1993 - December 1995)
Deborah McGill Education
University of Pennsylvania
M.S.E. (Biotechnology/Bioinformatics)
1998-2000
Virginia Commonwealth University
Ph.D. (Pharmacology/Toxicology)
1987-1993
Providence College
B.S. (Biology, Chemistry)
1983-1987
Deborah McGill Skills
Lifesciences
Clinical Research
Biotechnology
Pharmaceutical Industry
Regulatory Affairs
Drug Development
Collaborative Environment
Clinical Trials
Clinical Development
Therapeutic Areas
Life Sciences
FDA
IND
Regulatory Requirements
Regulatory Submissions
Drug Discovery
Deborah McGill Summary
Deborah McGill, based in Wilmington, DE, US, is currently a Associate Vice President, Global Regulatory Affairs at Incyte. Deborah McGill brings experience from previous roles at Incyte and PRA Health Sciences. Deborah McGill holds a 1998 - 2000 M.S.E. in Biotechnology/Bioinformatics @ University of Pennsylvania. With a robust skill set that includes Lifesciences, Clinical Research, Biotechnology, Pharmaceutical Industry, Regulatory Affairs and more. Deborah McGill has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Deborah McGill?
Find contact details for 700 million professionals.